PaxMedica logo.jpg
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments
13 mars 2024 08h20 HE | PaxMedica, Inc.
TARRYTOWN, New York, March 13, 2024 (GLOBE NEWSWIRE) -- via IBN – PaxMedica, Inc. (NASDAQ:PXMD), a biopharmaceutical company focused on advancing treatments for neurological disorders, today...
Horizontal-Logo-Tagline Lockup-onWhitebkd-01 (6)[31].png
BlueSprig Pediatrics Sponsors Armani Williams Ahead of the Daytona ARCA 200
12 févr. 2024 09h00 HE | BlueSprig Pediatrics, Inc.
DAYTONA BEACH, Fla., Feb. 12, 2024 (GLOBE NEWSWIRE) -- Blue Sprig Pediatrics, Inc. (BlueSprig), a leader in Applied Behavior Analysis (ABA) therapy for children diagnosed with Autism Spectrum...
Stalilcla logo.png
Stalicla Secures $17.4 Million in Series B Financing to Propel Precision Neuro Advancements
16 janv. 2024 06h00 HE | STALICLA
Geneva, Switzerland, January 16th, 2024 – Stalicla SA, a clinical-stage biopharmaceutical company advancing precision medicine pipelines for neuropsychiatric and neurological disorders, announces the...
Xolv
Xolv Creates a New Venture to Embark on New Era of Innovation in Behavioral Health
03 janv. 2024 16h53 HE | Xolv
WALNUT CREEK, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Xolv, formerly Catalight’s IT and technology innovation group, proudly announces its transition to a new corporation today as part of a...
NeuroQure Logo.png
NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample
13 déc. 2023 09h30 HE | NeuroQure
IRVINE, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the...
Autism Spectrum Disorder Treatment Market Globenewswire
Autism Spectrum Disorder Treatment Market Size to Surpass USD 13.14 Billion by 2030, exhibiting a CAGR of 8.5%
27 nov. 2023 06h14 HE | Fortune Business Insights
Pune, India, Nov. 27, 2023 (GLOBE NEWSWIRE) -- The autism spectrum disorder treatment market size was valued at USD 6.94 billion in 2022, and it is anticipated to expand from USD 7.41 billion in...
Lindsey Sneed
Study: Autistic Children May Need Fewer Hours of Treatment Than Previously Thought
21 nov. 2023 13h41 HE | Catalight
Walnut Creek, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Each year, tens of thousands of parents and caregivers of children with autism spectrum disorder (ASD) face vital decisions: What kind of...
YAMO LOGO-hi rez.png
Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study Evaluating L1-79 to Treat the Core Symptoms of Autism Spectrum Disorder
20 nov. 2023 08h05 HE | Yamo Pharmaceuticals
Yamo Pharmaceuticals LLC has completed enrollment in its Phase 2 study evaluating L1-79 in adolescents with autism spectrum disorder (ASD).
NeuroQure Logo.png
Revolutionizing Care: NeuroQure’s Groundbreaking Path to Treating Genetic Intellectual Disabilities
06 nov. 2023 12h00 HE | NeuroQure
IRVINE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- NeuroQure has embarked on a transformative journey aimed at revolutionizing the treatment landscape for Fragile X Syndrome and Autism Spectrum...
PaxMedica logo.jpg
PaxMedica Announces 1-for-17 Reverse Stock Split
30 oct. 2023 11h30 HE | PaxMedica, Inc.
TARRYTOWN, N.Y. , Oct. 30, 2023 (GLOBE NEWSWIRE) -- via IBN — PaxMedica, Inc. (Nasdaq: PXMD), a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic drug...